P-61 LIVER TRANSPLANTATION IN HEPATOCARCINOMA: SURVIVAL AND RECURRENCE IN TRANSPLANTED PATIENTS WITH HEPATOCARCINOMA
Introduction: Hepatocellular carcinoma (HCC) is the most common malignant liver tumor. Liver transplantation (LT) is considered potentially curative, achieving a survival of 70% at 5 years and a tumor recurrence <15% when the Milan criteria are used. Objectives: To study the frequency of tumor re...
Main Authors: | Daniela García, Fodda Chelech, Andrea Jiménez, Alvaro Urzúa, Maximo Cattaneo, Juan Pablo Roblero, Alexis Iracheta, Jaime Poniachik |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Annals of Hepatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S166526812100123X |
Similar Items
-
P-59 LIVER TRANSPLANTATION: SIX YEARS EXPERIENCE IN A UNIVERSITY HOSPITAL OF CHILE
by: Hiru Chang, et al.
Published: (2021-09-01) -
P-62 INFECTIONS IN THE FIRST MONTH POST LIVER TRANSPLANTATION IN A TRANSPLANT CENTER IN CHILE
by: Gabriel Uribe, et al.
Published: (2021-09-01) -
Metachronous pulmonary and adrenal metastases after liver transplantation for hepatocarcinoma
by: Chen Shan-Wen, et al.
Published: (2011-11-01) -
Hepatocellular carcinoma and liver transplantation Hepatocarcinoma y trasplante hepático
by: M. García, et al.
Published: (2006-12-01) -
P-40 SEVERE AUTOIMMUNE HEPATITIS: CORTICOSTEROID THERAPY OR EARLY ENROLLMENT TO LIVER TRANSPLANTATION
by: Andrea Jiménez, et al.
Published: (2021-09-01)